Noevir Holdings Co., Ltd.
Research Noevir Holdings Co., Ltd. (4928.T) on Bullrun: market cap JPY 159.34B, P/E 19.7, dividend yield 4.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4928.T
- ExchangeTSE
- CountryJapan
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyJPY
- Market capJPY 159.34B
- P/E19.7
- Dividend yield4.9%
- Financial periodFY2025
- RevenueJPY 64.72B
- Revenue growth1.4%
- Net incomeJPY 8.03B
- Free cash flowJPY 5.41B
- Gross margin66.9%
Valuation Snapshot
latest market cap is JPY 159.34B; P/E is 19.7; dividend yield is 4.9%.
Peer valuation comparison
Latest P/E is 19.65x versus a Consumer Defensive sector median of 16.79x (17.0% above).
Latest dividend yield is 4.91% versus a Consumer Defensive sector median of 2.92% (68.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 64.72B | JPY 8.03B | JPY 5.41B | 66.9% | 235.1 | JPY 26.93B | JPY 742.00M | JPY 53.77B |
| FY2024 | JPY 63.82B | JPY 7.97B | JPY 8.11B | 67.6% | 233.34 | JPY 29.22B | JPY 828.00M | JPY 53.48B |
| FY2023 | JPY 62.55B | JPY 7.67B | JPY 6.57B | 68.0% | 224.66 | JPY 28.88B | JPY 914.00M | JPY 52.79B |
| FY2022 | JPY 61.14B | JPY 7.59B | JPY 5.23B | 68.8% | 222.2 | JPY 29.75B | JPY 1.01B | JPY 52.06B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 159.34B | 19.7 | 4.9% | 230 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 230 JPY, yield 4.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 230 JPY |
| FY2024 | 225 JPY |
| FY2023 | 220 JPY |
| FY2022 | 215 JPY |
About Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Noevir Holdings Co., Ltd.'s market cap?
Noevir Holdings Co., Ltd.'s market capitalization is JPY 159.34B.
What is Noevir Holdings Co., Ltd.'s P/E ratio?
Noevir Holdings Co., Ltd.'s price-to-earnings (P/E) ratio is 19.7.
Does Noevir Holdings Co., Ltd. pay a dividend?
Noevir Holdings Co., Ltd. has a dividend yield of 4.9%.
What does Noevir Holdings Co., Ltd. do?
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs.